EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Cardioembolic Stroke: Past Advancements, Current Challenges, and Future Directions

Yuji Kato, Kenta Tsutsui iD, Shintaro Nakano iD, Takeshi Hayashi, Satoshi Suda iD

International Journal of Molecular Sciences · 26.05.2024 · 25 (11) · 5777

DOI: 10.3390/ijms25115777 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 26.05.2024. Verfasst von Yuji Kato und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology and Cerebrovascular Medicine, Saitama Medical University International Medical Center, Hidaka 350-1298, Japan. Hauptthemen laut MEDLINE: Embolic Stroke, Atrial Fibrillation, Anticoagulants. Die Arbeit wurde bisher 31-mal zitiert (Crossref) und nennt 64 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Cardioembolic stroke accounts for over 20% of ischemic strokes and is associated with worse outcomes than other types of strokes. Atrial fibrillation (AF) is the most common risk factor for cardioembolic stroke. In this narrative review, we present an update about cardioembolic stroke mainly related to AF and atrial cardiopathy. Direct oral anticoagulants (DOACs) have revolutionized stroke prevention in patients with AF; however, their efficacy in preventing recurrent embolic stroke of unknown source remains uncertain. Various cardiac monitoring methods are used to detect AF, which is crucial for preventing stroke recurrence. DOACs are preferred over warfarin for AF-related stroke prevention; however, the timing of initiation after acute ischemic stroke is debated. Resuming anticoagulation after intracerebral hemorrhage in AF patients requires careful assessment of the risks. While catheter ablation may reduce the incidence of cardiovascular events, its effect on stroke prevention is unclear, especially in heart failure patients. Atrial cardiopathy is the emerging cause of embolic stroke of unknown source, which indicates atrial structural and functional disorders that can precede AF. Future research should focus on refining stroke risk prediction models, optimizing AF detection, understanding the roles of ablation and anticoagulation in stroke prevention, and establishing atrial cardiopathy as a therapeutic target, which could significantly reduce the burden of stroke.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Embolic StrokeAtrial FibrillationAnticoagulantsHumansRisk Factors

Stichwörter der Autor:innen

atrial cardiopathyatrial fibrillationdirect oral anticoagulantsembolic stroke of unknown source

Substanzen

Anticoagulants

Autor:innen und Institutionen

  • Department of Neurology and Cerebrovascular Medicine, Saitama Medical University International Medical Center, Hidaka 350-1298, Japan.
  • Department of Cardiology, Saitama Medical University International Medical Center, Hidaka 350-1298, Japan.
  • Department of Cardiology, Teikyo University School of Medicine, Tokyo 173-8605, Japan.

ORCID-Profile: Kenta Tsutsui, Shintaro Nakano, Satoshi Suda

Zitieren

APA

Kato, Y., Tsutsui, K., Nakano, S., Hayashi, T., & Suda, S. (2024). Cardioembolic Stroke: Past Advancements, Current Challenges, and Future Directions. International Journal of Molecular Sciences, 25(11), 5777. https://doi.org/10.3390/ijms25115777

Vancouver

Kato Y, Tsutsui K, Nakano S, Hayashi T, Suda S. Cardioembolic Stroke: Past Advancements, Current Challenges, and Future Directions. International Journal of Molecular Sciences. 2024;25(11):5777. doi:10.3390/ijms25115777

BibTeX
@article{Kato2024,
  author = {Kato, Yuji and Tsutsui, Kenta and Nakano, Shintaro and Hayashi, Takeshi and Suda, Satoshi},
  title = {Cardioembolic Stroke: Past Advancements, Current Challenges, and Future Directions},
  journal = {International Journal of Molecular Sciences},
  year = {2024},
  volume = {25},
  number = {11},
  pages = {5777},
  doi = {10.3390/ijms25115777}
}
Kostenlos starten →